Quarantine angst

Crisis as Catalyst The COVID-19 Impact on Innovation

Wednesday 13 May 20
|

Webinar on 19 May 2020

19 May 2020: Crisis as Catalyst

White paper by Shomit Ghose, Silicon Valley VC, managing director, partner at ONSET Ventures and member of international advisory board of Open Entrepreneurship - April 2020. Photo: engin akyurt on Unsplash

Quarantine angst

What does the jet engine have in common with penicillin, the world’s first antibiotic? Both, as it turns out, were born in 1928, but it took the crisis of the Second World War for either to be brought into the mainstream and deployed. The war’s stresses also served as catalyst to usher in both the nuclear age and the age of computing. All four of these developments then helped lay the foundation for human society for the remainder of the century, and indeed continue to do so today.

Read full white paper by Shomit Ghose here

BII Webinar: Crisis as catalyst

19 May 2020 from 16.00 to 17.00 CEST

BioInnovation Institute will host an online session on Health Tech, where they will be looking into the consequences the COVID-19 pandemic will have on healthcare.

Shomit Ghose, Tech investor and Adjunct Professor in Entrepreneurship at UC Berkeley, will be joining online sharing his perspectives.

Agenda

1. Introduction to BioInnovation Institute (BII) – Jens Nielsen, Chief Executive Officer, BII
2. Crisis as Catalyst – Shomit Ghose, General Partner, ONSET Ventures
3. Supporting health tech start-ups at BII – Markus J. Herrgård, Chief Technical Officer, BII